Banque Cantonale Vaudoise’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-800
Closed -$5K 753
2024
Q2
$5K Hold
800
﹤0.01% 955
2024
Q1
$8K Sell
800
-700
-47% -$7.12K ﹤0.01% 934
2023
Q4
$17K Buy
+1,500
New +$6.26K ﹤0.01% 910
2022
Q3
Sell
-1,500
Closed -$18K 1229
2022
Q2
$18K Hold
1,500
﹤0.01% 1139
2022
Q1
$9K Hold
1,500
﹤0.01% 1213
2021
Q4
$14K Hold
1,500
﹤0.01% 1214
2021
Q3
$17K Hold
1,500
﹤0.01% 1175
2021
Q2
$24K Hold
1,500
﹤0.01% 1144
2021
Q1
$21K Buy
+1,500
New +$24.3K ﹤0.01% 1074

Other funds holding ALT

Banque Cantonale Vaudoise's ALT Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Altimmune (ALT) in Q3 2024, closing a stake of 800 shares — an estimated $5K sold.

Banque Cantonale Vaudoise first reported a position in ALT in Q1 2021 and held it in 9 quarters. The position peaked at $24K in Q2 2021. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 800 Altimmune shares in Q3 2024, an estimated $5K.
  • Banque Cantonale Vaudoise first reported a position in Altimmune in Q1 2021 and held it in 9 quarters.
  • Banque Cantonale Vaudoise's Altimmune position peaked at $24K in Q2 2021.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.